Quick Answer
BIOMERICA INC reported Total Revenue of $5.31 million for the year ending 2025.
- BIOMERICA INC showed a decrease of -1.9% in Total Revenue from 2024 to 2025.
- This data is from BIOMERICA INC's annual report (Form 10-K), filed with the SEC on August 29, 2025.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $1.50 million | Q3 2017: $1.44 million | Q4 2017: $1.61 million | Q1 2018: $1.38 million | Q3 2018: $1.27 million | Q4 2018: $1.50 million | Q1 2019: $1.26 million | Q3 2019: $1.19 million | Q4 2019: $1.60 million | Q1 2020: $1.18 million | Q3 2020: $1.14 million | Q4 2020: $1.37 million | Q1 2021: $3.63 million | Q3 2021: $1.26 million | Q4 2021: $4.65 million | Q1 2022: $7.66 million | Q3 2022: $1.64 million | Q4 2022: $1.48 million | Q1 2023: $1.11 million | Q3 2023: $1.71 million | Q4 2023: $1.57 million | Q1 2024: $1.02 million | Q3 2024: $1.81 million | Q4 2024: $1.64 million | Q1 2025: $1.12 million | Q3 2025: $1.38 million | Q4 2025: $1.21 million.
- Over the full 9 years of available data (2017 to 2025), BIOMERICA INC's Total Revenue has declined by 8.3%.
- Historical annual values: Fiscal year 2025: $5.31 million | Fiscal year 2024: $5.42 million | Fiscal year 2023: $5.34 million | Fiscal year 2022: $18.87 million | Fiscal year 2021: $7.20 million | Fiscal year 2020: $6.69 million | Fiscal year 2019: $5.20 million | Fiscal year 2018: $5.56 million | Fiscal year 2017: $5.79 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: